CRISPR

formerly CRISPR Therapeutics AG Common SharesIPO

Home | CRISPR Therapeutics

Public · Zug, Switzerland · Founded 2013 · $746.5M raised

Headquarters
Zug
Employees
201–500
Founded
2013
Business Model
B2B
Total Funding
$746.5M
Last Round
$280.0M Venture RoundFeb 2024
Rounds
9
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

CRISPR Therapeutics is a leading gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company has a diverse portfolio of product candidates spanning hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. In 2023, its co-developed therapy CASGEVY® became the first-ever approved CRISPR-based treatment, indicated for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics is headquartered in Zug, Switzerland, with its U.S. subsidiary and R&D operations in Boston, Massachusetts.

Summary

CRISPR is a Biotech company based in Zug, Switzerland, founded in 2013. It has raised $746.5M in total across 9 rounds, most recently a $280.0M Venture Round in Feb 2024. Investors include Versant Ventures, SR One and Bayer AG.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundFeb 2024
$280.0M

Sign up to see all 10 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CRISPR on Indexed.vc
<a href="https://indexed.vc/companies/crispr"><img src="https://indexed.vc/api/badge/company/crispr" alt="CRISPR on Indexed.vc" width="260" height="76" /></a>